Skip to main content

Table 2 Increases in CD4+ CD25+ T Cells after IL-2 Therapy; Percentages of CD25+ CD4+ T Cells

From: CD8 apoptosis may be a predictor of T cell number normalization after immune reconstitution in HIV

scIL-2 dose Baseline After 3 Cycles Change
7.5 MIU 1.0 ± 0.7 10.7 ± 6.7 9.7 ± 6.7
1.5 MIU 0.9 ± 0.6 3.9 ± 2.5 2.9 ± 2.6
Control 1.5 ± 0.9 2.9 ± 1.4 1.5 ± 1.1
  1. Percentages of CD25+ CD4+ T cells at baseline and after 3 cycles of scIL-2 therapy (week 24). The high dose IL-2 produced the greatest increase in CD25 percentages after scIL-2 administration. The high group had 4, the low group has 5 and none had 3.